Status:
WITHDRAWN
Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT
Lead Sponsor:
University of Miami
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study is examining the effects of the 2940 nm Er:YAG on atrophic facial acne scars under optical coherence tomography in terms of blood flow, vessel shape, skin roughness, collagen content, and e...
Eligibility Criteria
Inclusion
- Patients should be 18-90 years of age
- Patients should have Fitzpatrick skin types of I-III
- Patients should have at least mild acne
Exclusion
- The patient should not be receiving any additional systemic, topical, or intralesional treatment of the scars during the study
- Pregnant or lactating females
- Fitzpatrick skin type of IV-VI
- A history of keloids or hypertrophic scars
- Scleroderma
- Photosensitivity
- Botulinum toxin injection, facial laser resurfacing, chemical peels, fillers, or usage of oral retinoid within the last 6 months
- Subjects with a known history of herpes simplex
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03333759
Start Date
August 1 2018
End Date
December 1 2018
Last Update
July 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sylvester Comprehensive Cancer Center
Miami, Florida, United States, 33130